- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: 18 Opioid Addiction Bills in the House
What we're reading, May 12, 2016: there are 18 bills in the House that address the opioid epidemic and Massachusetts residents don't think medical professionals are doing a good job carrying out a dying person's wishes.
There are 18 bills in the House that address the opioid addiction epidemic in the United States. According to The New York Times, the bills include measures that make it easier for doctors to treat patients with addiction, offer greater protections for veterans and children affected, and a study of laws aimed at shielding providers and law enforcement who help treat opioid addicts. The House bills are expected to be packaged together after approval, at which point they need to be reconciled with similar legislation in the Senate.
How well do medical professional do with carrying out a dying person’s wishes? In a poll of Massachusetts residents, only one-third of people with a relative who had died said their wishes were fully carried out, reported the Boston Globe. Furthermore, the telephone survey of nearly 2000 residents found that 20% said end-of-life care for their loved was fair or poor. Responses suggest that a lack of planning by doctors and patients lead to turmoil and misunderstanding during the last days of a person’s life.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More
